The FHIT gene at 3p14.2 is abnormal in lung cancer

Cell

Volumn 85, Issue 1, 1996, Pages 17-26

  Sozzi, Gabriella ^a,b   Veronese, Maria Luisa ^a   Negrini, Massimo ^a   Baffa, Raffaele ^a   Cotticelli, Maria Grazia ^a   Inoue, Hiroshi ^a   Tornielli, Silvana ^b   Pilotti, Silvana ^b   De Gregorio, Laura ^b   Pastorino, Ugo ^b   Pierotti, Marco A ^b   Ohta, Masataka ^a   Huebner, Kay ^a   Croce, Carlo M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARCINOGENESIS; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL;

EID: 15844384990     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81078-8     Document Type: Article

References (40)

1. Baker, J.C., and Jacobson, M.K. (1986). Alteration of adenyl dinucleotide metabolism by environmental stress. Proc. Natl. Acad. Sci. USA 83, 2350-2352.
2. Barsky, S.H., Grossman, D.A., Ho, J., and Holmes, E.C. (1994). The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Mod. Pathol. 7, 633-640.
3. 4A binding protein by photoaffinity labeling. Biochemistry 33, 14601-14607.
4. Brauch, H., Johnson, B., Hovis, J., Yano, T., Gadzar, A., Pettengil, O., Graziano, S., Sorenson, G., Poiesz, B., Minna, J., Linehan, M., and Zbar, B. (1987). Molecular analysis of the short arm of chromosome 3 in small-cell and non-small cell carcinoma of the lung. N. Engl. J. Med. 317, 1109-1113.
5. Chiba, I., Takahashi, T., Nau, M.M., D'Amico, D., Curiel, D.T., Mitsudomi, T., Buchhagen, D.L., Carbone, D., Piantadosi, S., Koga, H., Reissmann, P., Slamon, D., Holmes, E., and Minna, J. (1990). Mutation in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene 5, 1603-1610.
6. Daly, M.C., Douglas, J.B., Bleehen, N.M., Hastleton, P., Twentyman, P.R., Sundaresan, V., Carrit, B., Bergh, J., and Rabbitts, P.M. (1991). An unusually proximal deletion on the short arm of chromosome 3 in a patient with small cell lung cancer. Genomics 9, 113-119.
7. Daly, M.C., Xiang, R.H., Buchhagen, D., Hensel, C.H., Garcia, D.K., Killary, A.M., Minna, J.D., and Naylor, S.L. (1993). A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity. Oncogene 8, 1721-1729.
8. Druck, T., Kastury, K., Hadaczek, P., Podolski, J., Toloczko, A., Sikorski, A., Ohta, M., La Forgia, S., Lasota, J., McCue, P., Lubinski, J., and Huebner, K. (1995). Loss of heterozygosity at the familial RCCt(3;8) locus in most clear cell renal carcinoma. Cancer Res. 55, 5348-5353.
9. Ebina, M., Steinberg, S.M., Mulshine, J.L., and Linnoila, R.I. (1994). Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res. 54, 2496-2503.
10. Harbour, J.W., Lai, S.L., Whang-Peng, J., Gazdar, A.F., Minna, J.D., and Kaye, F.J. (1988). Abnormalities in structure and expression of the human retinoblastoma gene. Science 241, 353-357.
11. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M., Takagi, H., Nakamura, Y., and Takahashi, T. (1992). Three distinct regions involved in 3p deletions in human lung cancer. Oncogene 7, 445-449.
12. Horio, Y., Takahashi, T., Kuroishi, T., Hibi, K., Suyama, M., Niimi, T., Shimokata, K., Yamakawa, K., Nakamura, Y., Ueda, R., and Takahashi, T. (1993). Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res. 53, 1-4.
13. 4A) asymmetrical hydrolase: sequence similarity with histidine triad (HIT) family. Biochem. J. 312, 925-932.
14. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D.D., Minna, J.D., and Gadzar, A.F. (1995). Allele specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc. 273, 558-563.
15. International Union against Cancer (1987). TNM classification of malignant tumors, Fourth Edition (Geneva: World Health Organization).
16. Kastury, K., Baffa, R., Druck, T., Ohta, M., Cotticelli, M.G., Inoue, H., Negrini, M., Rugge, M., Huang, D., Croce, C.M., Palazzo, J., and Huebner, K. (1996). Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res. 56, 978-983.
17. Killary, A.M., Wolf, M.E., Giambernardi, T.A., Naylor, S.L. (1992). Definition of a tumor suppressor locus within human chromosome 3p21-p22. Proc. Natl. Acad. Sci. USA 89, 10877-10881.
18. Kim, S.Y., Lee, J.S., Ro, J.Y., Gay, M.L., Hong, W.K., and Hittelman, W.N. (1993). Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization: mapping genotype/ phenotype heterogeneity. Am. J. Pathol. 142, 307-317.
19. Kok, H., Osinga, J., Carrit, B., Davis, M.B., van der Veen, A.Y., Landsvater, R.M., de Leij, L.F.M.H., Berendsen, H.H., Postmus, P.E., Poppema, S., and Buys, C.H.C.M. (1987). Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature 330, 578-581.
20. Kok, K., Hosfra, R., Pilz, A., van den Berg, A., Terpstra, P., Buys, C.H., and Carrit, B. (1993). A gene in the chromosomal region 3p21 with greatly reduced expression in lung cancer is similar to the gene for ubiquitin activating enzyme. Proc. Natl. Acad. Sci. USA 90, 6071-6075.
21. Kok, K., van den Berg, A., Veldhuis, P.M., van der Veen, A.Y., Franke, M., Shoenmakers, E.F., Hulsbeek, M.M., van der Hout, A.H., de Leij, L., van de Ven, W., and Buys, C.H.C.M. (1994). A homozygous deletion in a small cell lung cancer cell line involving a 3p21 region with a marked instability in yeast artificial chromosomes. Cancer Res. 54, 4183-4187.
22. Mitsudomi, T., Steinberg, S.M., Nau, M.M., Carbone, D., D'Amico, D., Bodner, S., Oie, H.K., Linnoila, R.I., Mulshine, J.L., Minna, J.D., and Gadzar, A.F. (1992). p53 mutations in non small cell lung cancer cell lines and their correlations with the presence of RAS mutations and clinical features. Oncogene 7, 171-180.
23. Murata, M., Otsuka, M., Hayakawa, Y., Takahashi, E., Tsuji, H., and Hori, T. (1992). Expressivity of a common fragile site, fra(3)(p14.2), in patients with cancer and other diseases. Jpn. J. Hum. Genet. 37, 205-213.
24. Naylor, S.L., Johnson, B.E., Minna J.D., and Sakaguchi, A.Y. (1987). Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 329, 451-454.
25. Ohta, M., Inoue, H., Cotticelli, M.G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C.M., and Huebner, K. (1996). The human FHITgene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated translocation breakpoint, is abnormal in digestive tract cancers. Cell 84, 587-597.
26. Rabbitts, P., Douglas, J., Daly, M., Sundaresan, V., Fox, V., Haselton, P., Wells, F., Albertson, D., Waters, J., and Bergh, J. (1989). Frequency and extent of allelic loss in the short arm of chromosome 3 in non small-cell lung cancer. Genes Chromosom. Cancer 1, 95-105.
27. Rabbitts, P., Bergh, J., Douglas, J., Collins, F., and Waters, J. (1990). A submicroscopic homozygous deletion at the D3S3 locus in a cell line isolated from a small cell lung carcinoma. Genes Chromosom. Cancer 2, 231-238.
28. Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press).
29. Satoh, H., Lamb, P.W., Dong, J.T., Everitt, J., Boreiko, C., Oshimura, M., and Barrett, J.C. (1993). Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosome 3 and 11 introduced via microcell-mediated chromosome transfer. Mol. Carcinog. 7, 157-164.
30. Sekido, Y., Bader, S., Latif, F., Gnarra, J.R., Gadzar, A.F., Linehan, M., Zbar, B., Lerman, M.I., and Minna, J.D. (1994). Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 9, 1599-1604.
31. Sozzi, G., Miozzo, M., Tagliabue, E., Calderone, C., Lombardi, L., Pilotti, S., Pastorino, U., Pierotti, M.A., and Della Porta, G. (1991). Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Res. 51, 400-404.
32. Sundaresan, V., Ganly, P., Hasleton, P., Rudd, R., Sinha, G., Bleehen, N.M., and Rabbitts, P. (1992). p53 and chromosome 3 abnormalities, characteristic of malignant lung tumors, are detectable in preinvasive lesions of the bronchus. Oncogene 7, 1989-1997.
33. Takahashi, T., Nau, M., Chiba, I., Birrer, M., Rosenberg, R., Vinocour, M., Levitt, M., Pass, H., Gazdar, A., and Minna, J.D. (1989). p53: a frequent target for genetic abnormalities in lung cancer. Science 246, 491-494.
34. Testa, J.R., Siegfried, Z.L., Hunt, J.D., Feder, M.M., Litwin, S., Zhou, J.Y., Taguchi, T., and Keller, S.M. (1994). Cytogenetic analysis of 63 non-small cell lung carcinomas: recurrent chromosome alterations amid frequent and widespread genomic upheaval. Genes Chromosom. Cancer 11, 178-194.
35. Weinmann-Dorsch, C., Grummt, I., Albert, W., Ferdinand, F.J., Friss, R.R., Pierron, G., Moll, W., and Grummt, F. (1984). Drastic rise of intracellular adenosine (5′) tetraphospho(5′) adenosine correlates with onset of DNA synthesis in eukaryotic cells. Eur. J. Biochem. 138, 179-185.
36. Whang-Peng, J., KaoShan, C.S., Lee, E.C., Bunn, P.A., Carney, D.N., Gazdar, A.F., and Minna, J.D. (1982). Specific chromosome defect associated with human small-cell lung cancer. Science 215, 181-182.
37. World Health Organization (1981). Histological Typing of Lung Tumors, Second Edition (Geneva: World Health Organization).
38. Xu, H.J., Quinlan, D.C., Davidson, A.G., Hu, S.X., Summers, C.L., Li, J., and Benedict, W.F. (1994). Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J. Natl. Cancer Inst. 86, 695-699.
39. Yokota, A., Wada, M., Shimosato, Y., Terada, M., and Sugimura, T. (1987). Loss of heterozygosity on chromosomes 3, 13, 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA 84, 9252-9256.
40. Yokoyama, S., Yamakawa, K., Tsuchiya, E., Murata, M., Sakiyama, S., and Nakamura, Y. (1992). Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 52, 873-877.